FDA OKs Cartridge-Based Companion Diagnostic Test for Colorectal Cancer
The test provides fully automated, sample-to-result testing to identify patients eligible for immunotherapy treatment.
The test provides fully automated, sample-to-result testing to identify patients eligible for immunotherapy treatment.
Greer Massey, PhD, chief scientific officer at Molecular Designs, shares insights on how labs are affected by the rule’s reversal and how they can prepare for future regulatory changes.
The phase 2B trial of vapendavir will use bioMérieux’s Biofire Spotfire panel—a CLIA-waived molecular test that detects rhinovirus—to confirm infections in COPD patients.
The new platform offers three-tiered approach to help laboratories at different stages of data maturity extract actionable insights from operational data.
Seattle startup will use funding to develop urine-based tuberculosis test using engineered NovoBodies technology for low-resource settings.